Cascadian Therapeutics Reports Fourth Quarter and Full Year 2016 Financial Results
SEATTLE, March 09, 2017 (GLOBE NEWSWIRE) -- Cascadian Therapeutics, Inc. (NASDAQ:CASC) today reported financial results for the fourth quarter and full year ended December 31, 2016. “In 2016, we focused our efforts on the development of tucatinib for late- …